LEGAL STEROIDS - AN OVERVIEW

At the end of their cycle, hematocrit levels had increased by 3%-level compared with baseline. The increase wasn't associated with lengthier use or better AAS dose. A basis for this could be that, further than a certain level of androgenic activity, no further more raise of hematocrit takes place: a ‘ceiling impact’. Notably, Whilst only 5% of